Business
Bausch + Lomb Receives FDA 510(k) Clearance for Bi-Blade+™ Dual-Port Vitrectomy Cutter and Adaptive Fluidics™ Advanced Update
VAUGHAN, Ontario, April 08, 2026--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the U.S. Food and Drug Administration has granted 510(k) clearance for the Bi-Blade+ advanced dual-port vitrectomy cutter and the Adaptive Fluidics advanced update on the Stellaris Elite® Vision Enhancement System.
About this update from Bausch + Lomb Corporation
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":354,"height":480,"url":"https://media.zenfs.com/en/business-wire.com/d899f8076e8ab19925839fd06a74a06f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/.VW7MFUlN2KdMix.y54nHQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTk1Ng--/https://media.zenfs.com/en/business-wire.com/d899f8076e8ab19925839fd06a74a06f","width":354,"height":480}},"lazy":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":4152,"height":327,"url":"https://media.zenfs.com/en/business-wire.com/2a32836e8f8a574a2cd41001e2a8d149"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/o1usCGw7mxPtdodAtWhYQQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTc2/https://media.zenfs.com/en/business-wire.com/2a32836e8f8a574a2cd41001e2a8d149","width":960,"height":76},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/eD1gGJ.57gtVO2_uevuGsA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0xOTA-/https://media.zenfs.com/en/business-wire.com/2a32836e8f8a574a2cd41001e2a8d149","width":1200,"height":95}}},{"type":"list","items":[{"val":[{"type":"text","content":"Increased cutting speed of 25,000 cuts per minute1 is designed to minimize retinal traction,2 increase vitreous flow,1 and reduce infusion pressure fluctuations when used with Adaptive Fluidics.3*","length":196,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Bi-Blade+ provides an average flow rate increase of 25%, enabling more efficient vitreous removal compared to Bi-Blade®.1*†","length":123,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"The resulting stability, efficiency and control help boost confidence for retina surgeons to deliver exceptional patient outcomes.","length":130,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":449,"olType":false},{"type":"text","content":"VAUGHAN, Ontario, April 08, 2026--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the U.S. Food and Drug Administration has granted 510(k) clearance for the Bi-Blade+ advanced dual-port vitrectomy cutter and the Adaptive Fluidics advanced update on the Stellaris Elit...